Sean Lavin
Stock Analyst at BTIG
(1.91)
# 1,612
Out of 4,479 analysts
28
Total ratings
73.33%
Success rate
34.4%
Average return
Main Sectors:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Downgrades: Neutral | n/a | $73.53 | - | 1 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $197.19 | +62.28% | 4 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $77.37 | - | 1 | Jan 10, 2022 | |
| MASI Masimo | Downgrades: Neutral | n/a | $113.42 | - | 2 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $0.97 | - | 3 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | n/a | $98.61 | - | 2 | Apr 3, 2019 | |
| ATRC AtriCure | Upgrades: Buy | n/a | $22.39 | - | 2 | Apr 2, 2019 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $11.32 | - | 3 | Jun 4, 2018 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $13.73 | - | 3 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $43.17 | - | 2 | Apr 3, 2018 | |
| ABT Abbott Laboratories | Downgrades: Neutral | n/a | $103.20 | - | 1 | Jan 22, 2018 | |
| AXDX Accelerate Diagnostics | Downgrades: Neutral | n/a | $1.15 | - | 1 | Dec 13, 2017 | |
| BSX Boston Scientific | Upgrades: Buy | n/a | $76.55 | - | 1 | Nov 30, 2017 | |
| DXCM DexCom | Downgrades: Neutral | n/a | $112.49 | - | 1 | May 3, 2017 | |
| EW Edwards Lifesciences | Downgrades: Neutral | n/a | $91.23 | - | 1 | Feb 2, 2017 |
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $73.53
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $197.19
Upside: +62.28%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $77.37
Upside: -
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $113.42
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $0.97
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: n/a
Current: $98.61
Upside: -
AtriCure
Apr 2, 2019
Upgrades: Buy
Price Target: n/a
Current: $22.39
Upside: -
Tactile Systems Technology
Jun 4, 2018
Downgrades: Neutral
Price Target: n/a
Current: $11.32
Upside: -
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $13.73
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $43.17
Upside: -
Abbott Laboratories
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $103.20
Upside: -
Accelerate Diagnostics
Dec 13, 2017
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
Boston Scientific
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $76.55
Upside: -
DexCom
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $112.49
Upside: -
Edwards Lifesciences
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $91.23
Upside: -